Newstral
Article
apnews.com on 2021-12-20 16:25
Biogen cuts the price tag on its Alzheimer's drug in half - Mon, 20 Dec 2021 PST
Related news
- Biogen cuts the price for its Alzheimer’s drug in halfpressherald.com
- Biogen cuts the price tag on its Alzheimer’s drug in halfjournalrecord.com
- HBiogen Cuts the Price Tag on its Alzheimer’s Drug in Halfhamodia.com
- Biogen cutting cost of Alzheimer's drugArkansas Online
- Biogen seeks new chief, cuts Aduhelm spendingArkansas Online
- Biogen shares soar as FDA reviewers support Alzheimer's drugSydney Morning Herald
- Change at the top for Biogen after Alzheimer's drug flops - Tue, 03 May 2022 PSTapnews.com
- Biogen cuts Alzheimer’s drug price 50% months after approvalSeattle Times
- MBiogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min readmarketwatch.com
- WAlzheimer's drug from Biogen, partner receives FDA approvalwraltechwire.com
- Biogen reanalyzes studies, presses ahead on Alzheimer's druglasvegassun.com
- MBiogen talks up approval plans for controversial Alzheimer's drug as it nears FDA decisionmarketwatch.com
- MOne Alzheimer's drug has failed, but investors are still betting on Biogen and Lilly treatments 2 min readmarketwatch.com
- BFDA Will Weigh Full Approval for Alzheimer's Drug. Why It Matters for Biogen Stock. 3 min readbarrons.com
- FDA calls for investigation of Biogen Alzheimer's drug approvalbizjournals.com
- Biogen to cease production of controversial Alzheimer's drugPOLITICO